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ゾールは粘膜免疫系のT helper ₁  type（Th ₁ ）／ T helper 
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Abstract
THE ROLE OF COGNITIVE FACTORS IN THE BRAIN-GUT 
CONNECTION IN IRRITABLE BOWEL SYNDROME
Nagisa Sugaya
Department of Epidemiology and Public Health, 
Graduate School of Medicine, Yokohama City Univercity
　Irritable bowel syndrome (IBS) is a gastrointestinal psychosomatic disorder, and the onset and course of IBS are 
influenced by psychological factors. The central nervous system and gut influence each other, and this relationship 
is reportedly mediated by the hypothalamic-pituitary-adrenal (HPA) axis, autonomic nervous system, immune 
system, or some combination thereof. This brain-gut network has an important role in pathophysiology of IBS. 
Individuals with IBS need both mental and physical interventions, and the utility of cognitive therapy or cognitive 
behavioral therapy has been demonstrated. Recently, the relationship between various biological variables relating 
to the brain-gut axis and the effect of cognitive behavioral therapy or cognitive factors has been examined. For 
example, IBS patients showed a strong negative correlation between dorsolateral prefrontal cortex thickness and 
pain catastrophizing. Individuals with IBS showed a significant correlation between salivary adrenal hormone and 
low controllability for acute stressors. Moreover, an interventional study found that neural activity in the 
parahippocampal gyrus and the inferior portion of the right cortex cingulate were reduced after cognitive therapy, 
and limbic activity changes were accompanied by significant improvements in GI symptoms and anxiety. An 
improved understanding of the role of cognitive factors in the brain-gut axis may contribute to development of 
psychological interventions, including cognitive behavioral therapy, that are suitable for IBS.
